These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 31685398)

  • 1. Interplay between host-microbe and microbe-microbe interactions in cystic fibrosis.
    Armbruster CR; Coenye T; Touqui L; Bomberger JM
    J Cyst Fibros; 2020 Mar; 19 Suppl 1(Suppl 1):S47-S53. PubMed ID: 31685398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Viral-Bacterial Co-infections in the Cystic Fibrosis Respiratory Tract.
    Kiedrowski MR; Bomberger JM
    Front Immunol; 2018; 9():3067. PubMed ID: 30619379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The polymicrobial nature of airway infections in cystic fibrosis: Cangene Gold Medal Lecture.
    Sibley CD; Surette MG
    Can J Microbiol; 2011 Feb; 57(2):69-77. PubMed ID: 21326348
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Kiedrowski MR; Gaston JR; Kocak BR; Coburn SL; Lee S; Pilewski JM; Myerburg MM; Bomberger JM
    mSphere; 2018 Aug; 3(4):. PubMed ID: 30111629
    [No Abstract]   [Full Text] [Related]  

  • 5. Host-pathogen interplay in the respiratory environment of cystic fibrosis.
    Yonker LM; Cigana C; Hurley BP; Bragonzi A
    J Cyst Fibros; 2015 Jul; 14(4):431-439. PubMed ID: 25800687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Innate immunity in cystic fibrosis lung disease.
    Hartl D; Gaggar A; Bruscia E; Hector A; Marcos V; Jung A; Greene C; McElvaney G; Mall M; Döring G
    J Cyst Fibros; 2012 Sep; 11(5):363-82. PubMed ID: 22917571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial resistance in the respiratory microbiota of people with cystic fibrosis.
    Sherrard LJ; Tunney MM; Elborn JS
    Lancet; 2014 Aug; 384(9944):703-13. PubMed ID: 25152272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Help, hinder, hide and harm: what can we learn from the interactions between
    Limoli DH; Hoffman LR
    Thorax; 2019 Jul; 74(7):684-692. PubMed ID: 30777898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. One versus Many: Polymicrobial Communities and the Cystic Fibrosis Airway.
    Jean-Pierre F; Vyas A; Hampton TH; Henson MA; O'Toole GA
    mBio; 2021 Mar; 12(2):. PubMed ID: 33727344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbial ecology and adaptation in cystic fibrosis airways.
    Yang L; Jelsbak L; Molin S
    Environ Microbiol; 2011 Jul; 13(7):1682-9. PubMed ID: 21429065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cystic fibrosis airway microbiome.
    Rabin HR; Surette MG
    Curr Opin Pulm Med; 2012 Nov; 18(6):622-7. PubMed ID: 22965275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions between Pseudomonas aeruginosa and Staphylococcus aureus during co-cultivations and polymicrobial infections.
    Nguyen AT; Oglesby-Sherrouse AG
    Appl Microbiol Biotechnol; 2016 Jul; 100(14):6141-6148. PubMed ID: 27236810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cystic fibrosis microbiome in an ecological perspective and its impact in antibiotic therapy.
    Magalhães AP; Azevedo NF; Pereira MO; Lopes SP
    Appl Microbiol Biotechnol; 2016 Feb; 100(3):1163-1181. PubMed ID: 26637419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recapitulation of polymicrobial communities associated with cystic fibrosis airway infections: a perspective.
    O'Brien TJ; Welch M
    Future Microbiol; 2019 Nov; 14():1437-1450. PubMed ID: 31778075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tracking Polymicrobial Metabolism in Cystic Fibrosis Airways:
    Gao B; Gallagher T; Zhang Y; Elbadawi-Sidhu M; Lai Z; Fiehn O; Whiteson KL
    mSphere; 2018 Apr; 3(2):. PubMed ID: 29695623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genotypic and Phenotypic Diversity of Staphylococcus aureus Isolates from Cystic Fibrosis Patient Lung Infections and Their Interactions with Pseudomonas aeruginosa.
    Bernardy EE; Petit RA; Raghuram V; Alexander AM; Read TD; Goldberg JB
    mBio; 2020 Jun; 11(3):. PubMed ID: 32576671
    [No Abstract]   [Full Text] [Related]  

  • 17. Reconciling Antimicrobial Susceptibility Testing and Clinical Response in Antimicrobial Treatment of Chronic Cystic Fibrosis Lung Infections.
    Waters VJ; Kidd TJ; Canton R; Ekkelenkamp MB; Johansen HK; LiPuma JJ; Bell SC; Elborn JS; Flume PA; VanDevanter DR; Gilligan P;
    Clin Infect Dis; 2019 Oct; 69(10):1812-1816. PubMed ID: 31056660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cystic fibrosis lung environment and Pseudomonas aeruginosa infection.
    Bhagirath AY; Li Y; Somayajula D; Dadashi M; Badr S; Duan K
    BMC Pulm Med; 2016 Dec; 16(1):174. PubMed ID: 27919253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Infections of the respiratory tract with Pseudomonas aeruginosa in cystic fibrosis].
    Winkler U; Wingender J; Jäger KE
    Klin Wochenschr; 1985 Jun; 63(11):490-8. PubMed ID: 3925219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disruption of Cross-Feeding Inhibits Pathogen Growth in the Sputa of Patients with Cystic Fibrosis.
    Flynn JM; Cameron LC; Wiggen TD; Dunitz JM; Harcombe WR; Hunter RC
    mSphere; 2020 Apr; 5(2):. PubMed ID: 32350096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.